Folks, V&C1 is apparently opposed to research into treatment for Respiratory Syncytial Virus (RSV), Seasonal Influenza, Cytomegalovirus, Cancer, Heart disease, and Cystic fibrosis.
One year after mass vaccination and mass immunosuppression of children with experimental mRNA; severe RSV illness in children reached record levels in 2022.
Weaker immune systems after over vaccination and unknown long term effects with MUDERNA shots and now Murderna wants to now bring an RSV mRNA experiment to market.
Good to know that Reuters has regained acceptance from V&C1.
I have to ask though folks, given that as of Jan 4 2023 - 12 days ago - neither Moderna, Pfizer, nor GlaxoSmithKline have received FDA approval to market an RSV vaccine, what a year old announcement of a trial has to do with anything.
mass immunosuppression
She probably should try to provide some support for that statement. It seems funny since the vaccines are designed to give the immune system a heads-up that a new pathogen might arrive.
https://investors.modernatx.com/news/news-details/2023/Moderna-Announces-Advances-Across-mRNA-Pipeline-and-Provides-Business-Update/default.aspx
Get your boosters u/tuchodi! Your boy and Murderna expert, has just the shot for you after a sudden death side effect!
Folks, V&C1 is apparently opposed to research into treatment for Respiratory Syncytial Virus (RSV), Seasonal Influenza, Cytomegalovirus, Cancer, Heart disease, and Cystic fibrosis.
What a grinch.
Thank you for pointing out more murderna corruption Covid Nazi!
https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-begins-late-stage-study-rsv-vaccine-using-mrna-technology-2022-02-22/
One year after mass vaccination and mass immunosuppression of children with experimental mRNA; severe RSV illness in children reached record levels in 2022.
Weaker immune systems after over vaccination and unknown long term effects with MUDERNA shots and now Murderna wants to now bring an RSV mRNA experiment to market.
https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-begins-late-stage-study-rsv-vaccine-using-mrna-technology-2022-02-22/
Create the disease and charge even more for the cause.
Good to know that Reuters has regained acceptance from V&C1.
I have to ask though folks, given that as of Jan 4 2023 - 12 days ago - neither Moderna, Pfizer, nor GlaxoSmithKline have received FDA approval to market an RSV vaccine, what a year old announcement of a trial has to do with anything.
She probably should try to provide some support for that statement. It seems funny since the vaccines are designed to give the immune system a heads-up that a new pathogen might arrive.